Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel. - Wikidata - awgldk - TriplyDB

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

http://www.wikidata.org/entity/Q36311816

about

Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting Advances in HIV microbicide development A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria.Development of topical microbicides to prevent the sexual transmission of HIV Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Enhancement of HIV infection by cellulose sulfate.Topical microbicides and HIV prevention in the female genital tract Correlates of the molecular vaginal microbiota composition of African women.Non-specific microbicide product development: then and now Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1 Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception Vaginal microbicides and the prevention of HIV transmission Vaginal drug delivery systems for HIV prevention.Pharmaceutical development of microbicide drug products.HIV sexual transmission and microbicides.Evaluation of poly(lactic-co-glycolic acid) and poly(dl-lactide-co-ε-caprolactone) electrospun fibers for the treatment of HSV-2 infection.Evaluation of Vaginal Drug Levels and Safety of a Locally Administered Glycerol Monolaurate Cream in Rhesus Macaques.Designing and developing suppository formulations for anti-HIV drug delivery.Vaginal Mucosa and Drug Delivery

P2860

Q21133918-216E2954-E4EA-4256-BD96-318745E9B56A Q21199583-A7D3966F-FE3D-4811-AFB0-BFD1B655563A Q26852858-DCD7099D-D010-48CD-844B-7523F6ACB7A7 Q28743383-7D0EE05A-E772-49BE-B4B9-682425EEF447 Q30412592-4CB47ADB-8CE0-4DF9-A332-33B92EA59166 Q33386027-E33009A7-AF20-4B92-8691-FA5860D2991A Q33625073-DAA99C94-600F-4A90-80B5-57985FC259AD Q33880947-063B745A-473C-40E6-A7A5-11814BE26A58 Q33889449-12A0C0FA-B971-40A6-B3AE-29B89B0C792D Q34080823-447FA7CB-4E5E-4962-A2F1-7D459A84E463 Q34086820-2E8BB1F0-1DAD-4CF0-8545-C892EAF8D2DD Q35128707-C1827D54-8FB6-4D6C-B55D-AE07B82A4DCE Q35345283-7BE2FAC7-DAE6-4C08-B107-FED2C3505D6C Q35518190-9AE93B70-3FB4-4678-9D0C-5C98AAC50F19 Q35808786-B69BA56A-2327-402B-BB04-0671D8A68AF8 Q36016276-2376F182-5779-4BCC-923D-89C995A5B871 Q37063819-D36CF1B8-64D3-42FD-95C0-4CB20B67293D Q37149107-102410D2-35B1-475D-AAE8-42B6F4899563 Q37657468-E9D25A60-5C44-4055-B438-4BA0E28D984F Q37853935-3C19EF31-0D3B-4CB9-93BA-83D238F08109 Q39063908-99B03E83-704D-47AE-96A4-0CB6FBF91A47 Q40252689-5C91F241-0615-470A-B48D-9468ADF35618 Q53751650-F21980A7-DE09-4376-B12C-7A3EE41F7228 Q57570821-B940C08A-658A-4E2E-9866-2AA348892C7C

P2860

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

http://www.wikidata.org/entity/Q36311816

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@ast

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@en

type

label

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@ast

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@en

prefLabel

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@ast

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@en

P1433

Q36311816-9D85B7DE-A001-4F7E-AD70-348BB55990F6

P1476

Q36311816-67B5E817-FEB4-4BC0-9DF3-5C7E013B528A

P2093

Q36311816-74634F1C-EF41-433D-B614-75F3DCD2F896

Q36311816-7C223307-E4AC-42AD-9FDF-4CF9AF2CF482

Q36311816-81BC0FB3-E42A-475E-9F72-4EF243BC8732

Q36311816-9FB4D5CB-B94E-4E39-A6BE-5462C9F7C0AA

Q36311816-ACCD3027-28FA-4D12-B9CE-BBBFF2DD45A7

Q36311816-BD188966-87DF-4EE6-91CD-072C6D3DC97F

Q36311816-D0D7B047-96AA-4F27-9FA8-6B6DC203EEFE

Q36311816-D512EA91-85D3-4E23-9BF4-2E4269A7BF61

Q36311816-F107681C-104D-4896-A02B-8EFC57C20604

Q36311816-FF328DAB-8B8F-4ED3-B932-AB5A5B153FBF

P304

Q36311816-0A80D92C-5A44-4E89-AB41-9E604FDE843E

P31

Q36311816-B7D64DAF-93FD-4D01-9F38-1D650B852104

P356

Q36311816-96B39E65-9EE1-4068-8DCE-5E0D8CC9A9BD

P407

Q36311816-3756C98E-10CD-4710-8353-5E33945D2042

P433

Q36311816-46DA980C-80C4-4014-9E81-D40B9D5AB911

P478

Q36311816-9B092E8B-E3BC-4DAC-8DC7-2D4B40327819

P577

Q36311816-FF591B1D-C1BA-4911-95FC-E106E68D378D

P698

Q36311816-2E9E7061-E892-4640-BFEC-FC3292CAAA3E

P356

01.AIDS.0000194797.59046.8F

P1433

P1476

Expanded Phase I safety and acceptability study of 6% cellulose sulfate vaginal gel.

@en

P2093

Clemensia Nakabiito

http://www.w3.org/2001/XMLSchema#string

Florence Mirembe

http://www.w3.org/2001/XMLSchema#string

Isaac M Malonza

http://www.w3.org/2001/XMLSchema#string

Kamal Hazari

http://www.w3.org/2001/XMLSchema#string

Lawrence O Odusoga

http://www.w3.org/2001/XMLSchema#string

Lut Van Damme

http://www.w3.org/2001/XMLSchema#string

Marianne Callahan

http://www.w3.org/2001/XMLSchema#string

Mohamed M Ali

http://www.w3.org/2001/XMLSchema#string

Olubunmi A Osinupebi

http://www.w3.org/2001/XMLSchema#string

Shanta Chitlange

http://www.w3.org/2001/XMLSchema#string

P304

2157-2163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.AIDS.0000194797.59046.8F

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16284466

http://www.w3.org/2001/XMLSchema#string